Friday, 23 February, 2024
HomeMedico-LegalHerceptin patents overturned

Herceptin patents overturned

[b]Hospira[/b] has successfully overturned two patents on [b]Roche’s[/b] breast cancer drug [b]Herceptin[/b] in Britain, clearing the way for a cheaper copycat version in that country. [s]Reuters Health[/s] reports that this would ramp up competition for a costly cancer treatment and could drive down prices. The potential to use copycat forms of biotech drugs like Herceptin is gaining increased attention from cost-conscious health authorities across Europe.

[link url=] Full Reuters Health report[/link]

MedicalBrief — our free weekly e-newsletter

We'd appreciate as much information as possible, however only an email address is required.